[go: up one dir, main page]

DE3841397C2 - - Google Patents

Info

Publication number
DE3841397C2
DE3841397C2 DE19883841397 DE3841397A DE3841397C2 DE 3841397 C2 DE3841397 C2 DE 3841397C2 DE 19883841397 DE19883841397 DE 19883841397 DE 3841397 A DE3841397 A DE 3841397A DE 3841397 C2 DE3841397 C2 DE 3841397C2
Authority
DE
Germany
Prior art keywords
drug carrier
drug
varnish
collagen
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE19883841397
Other languages
German (de)
English (en)
Other versions
DE3841397A1 (de
Inventor
Des Erfinders Auf Nennung Verzicht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MELZER WOLFGANG DR 8000 MUENCHEN DE
Original Assignee
MELZER WOLFGANG DR 8000 MUENCHEN DE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MELZER WOLFGANG DR 8000 MUENCHEN DE filed Critical MELZER WOLFGANG DR 8000 MUENCHEN DE
Priority to DE19883841397 priority Critical patent/DE3841397A1/de
Publication of DE3841397A1 publication Critical patent/DE3841397A1/de
Application granted granted Critical
Publication of DE3841397C2 publication Critical patent/DE3841397C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
DE19883841397 1988-12-08 1988-12-08 Poroeser resorbierbarer arzneistofftraeger Granted DE3841397A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19883841397 DE3841397A1 (de) 1988-12-08 1988-12-08 Poroeser resorbierbarer arzneistofftraeger

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19883841397 DE3841397A1 (de) 1988-12-08 1988-12-08 Poroeser resorbierbarer arzneistofftraeger

Publications (2)

Publication Number Publication Date
DE3841397A1 DE3841397A1 (de) 1990-06-21
DE3841397C2 true DE3841397C2 (fi) 1992-11-12

Family

ID=6368740

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19883841397 Granted DE3841397A1 (de) 1988-12-08 1988-12-08 Poroeser resorbierbarer arzneistofftraeger

Country Status (1)

Country Link
DE (1) DE3841397A1 (fi)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989215A (en) * 1995-01-16 1999-11-23 Baxter International Inc. Fibrin delivery device and method for forming fibrin on a surface
US7135027B2 (en) 2002-10-04 2006-11-14 Baxter International, Inc. Devices and methods for mixing and extruding medically useful compositions
US7226657B1 (en) 1998-11-04 2007-06-05 Baxter International Inc. Element provided with a fibrin layer, preparation and use thereof

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736160A (en) * 1993-10-28 1998-04-07 Thm Biomedical, Inc. Process and device for treating and healing a bone void
DE4414755C2 (de) 1994-04-27 2000-11-16 Lohmann Therapie Syst Lts Kollagenzubereitung zur gesteuerten Abgabe von Wirkstoffen, Verfahren und Verwendung
US5981825A (en) * 1994-05-13 1999-11-09 Thm Biomedical, Inc. Device and methods for in vivo culturing of diverse tissue cells
AUPM897594A0 (en) * 1994-10-25 1994-11-17 Daratech Pty Ltd Controlled release container
EP0917444A1 (en) 1996-07-12 1999-05-26 Baxter Travenol Laboratories, Inc. A fibrin delivery device and method for forming fibrin on a surface
GB0006439D0 (en) * 2000-03-18 2000-05-10 Univ Nottingham Polymeric composite materials and their manufacture
AU2002212551A1 (en) * 2000-11-10 2002-05-21 Cambridge University Technical Services Limited Delivery devices
SI1677828T1 (sl) * 2003-10-21 2013-04-30 Psimedica Limited Kompozitni material, ki vsebuje porozen polprevodnik impregniran z organsko substanco
US20060069068A1 (en) * 2004-07-15 2006-03-30 Nanobac Pharmaceuticals, Inc. Methods and compositions for the treatment of diseases characterized by pathological calcification

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
US4563489A (en) * 1984-02-10 1986-01-07 University Of California Biodegradable organic polymer delivery system for bone morphogenetic protein

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989215A (en) * 1995-01-16 1999-11-23 Baxter International Inc. Fibrin delivery device and method for forming fibrin on a surface
US6074663A (en) * 1995-01-16 2000-06-13 Baxter International Inc. Method of using cross-linked fibrin material
US7226657B1 (en) 1998-11-04 2007-06-05 Baxter International Inc. Element provided with a fibrin layer, preparation and use thereof
US7135027B2 (en) 2002-10-04 2006-11-14 Baxter International, Inc. Devices and methods for mixing and extruding medically useful compositions
US7766919B2 (en) 2002-10-04 2010-08-03 Baxter International Inc. Devices for mixing and extruding medically useful compositions

Also Published As

Publication number Publication date
DE3841397A1 (de) 1990-06-21

Similar Documents

Publication Publication Date Title
DE69224131T2 (de) Polymerzusammensetzungen zur Verwendung als Implantate mit verzögerter Abgabe
DE69215360T2 (de) Bioresorbierbares implantat bestehend aus polymilchsäure und enthaltend antibiotika
DE2843963C2 (fi)
DE69332210T2 (de) Biologisch abbaubares, schmelzgesponnenes abgabesystem zur kontrollierten freisetzung
EP0202445B1 (de) Cytostatikhaltiges Pharmakadepot
DE69625822T2 (de) Implantierbare, bioresorbierbare membran und verfahren zu ihrer herstellung
DE69912836T2 (de) Zusammensetzungen enthaltend ein peptid und polymilch-glykolsäure geeignet für die herstellung von subkutanen implantaten mit verlängerter wirkstoffabgabe
DE60017956T2 (de) Biodegradierbare polymerzusammensetzung
DE69332346T2 (de) Material für Knochenprothese enthaltend in einer bioresorbierbaren Polymermatrix dispergierte Calciumcarbonatteilchen
DE69527042T2 (de) Biokompatible poröse matrix aus bioabsorbierendem material
DE3841397C2 (fi)
EP1519713B1 (de) Wirkstofffreisetzungssysteme auf basis von bioabbaubaren oder biokompatiblen polymeren mit formgedaechtniseffekt
DE2207635A1 (de) Polylactidhaltige pharmazeutische Zubereitungen
DE3710175A1 (de) Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung
DE2842088A1 (de) Arzneimittel mit verzoegerter wirkstoffabgabe
EP0086997B1 (de) Verfahren zur Herstellung einer pharmazeutischen Zubereitung in Form eines Polyacrylat-Films
EP0158277A2 (de) Implantierbare Zubereitungen von regulatorischen Peptiden mit gesteuerter Freisetzung und Verfahren zur ihrer Herstellung
EP1745806B1 (de) Verformbares Implantatmaterial
DE3124981A1 (de) Wirkstoffhaltige kollageneinlage zum einfuehren in knochen oder weichteile und verfahren zu deren herstellung
DE10254215A1 (de) Chirurgisches Implantat
EP0094513B1 (de) Wirkstoff enthaltender Körper für die Langzeitabgabe
DE69921636T2 (de) Medikamentöse verabreichung von proteinen aus polymergemischen
DE2917037B1 (de) Parenterale arzneimittelhaltige partiell resorbierbare Mehrkomponentenmasse auf Basis von polymeren Stoffen
EP0580689B1 (de) Verbesserte retard-systeme für die zeitverzögerte freigabe medizinischer und/oder biologischer wertstoffe aus einem depot-trägermaterial
DE2842089A1 (de) Arzneimittel mit verzoegerter wirkstoffabgabe

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee